Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MAYES MD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Furst, DE; Clements, PJ; Wong, WK; Mayes, MD; Wigley, F; White, B; Weisman, M; Barr, W; Moreland, L; Martin, R; Medsger, TA; Steen, V; Collier, D; Weinstein, A; Lally, E; Varga, J; Weiner, SR; Andrews, B; Abeles, M; Peter, JB; Seibold, JR
      Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial

      RHEUMATOLOGY
    2. Furspan, PB; Mayes, MD; Freedman, RR
      Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenon

      JOURNAL OF RHEUMATOLOGY
    3. Freedman, RR; Girgis, R; Mayes, MD
      Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma

      JOURNAL OF RHEUMATOLOGY
    4. Arnett, FC; Cho, M; Chatterjee, S; Aguilar, MB; Reveille, JD; Mayes, MD
      Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts

      ARTHRITIS AND RHEUMATISM
    5. Laing, TJ; Schottenfeld, D; Lacey, JV; Gillespie, BW; Garabrant, DH; Cooper, BC; Heeringa, SG; Alcser, KH; Mayes, MD
      Potential risk factors for undifferentiated connective tissue disease among women: Implanted medical devices

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    6. Mayes, MD
      Photopheresis and autoimmune diseases

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    7. Miller, FW; Hess, EV; Clauw, DJ; Hertzman, PA; Pincus, T; Silver, RM; Mayes, MD; Varga, J; Medsger, TA; Love, LA
      Approaches for identifying and defining environmentally associated rheumatic disorders

      ARTHRITIS AND RHEUMATISM
    8. Wigley, FM; Wise, R; Haythornthwaite, J; Rand, C; Smith, EA; Maricq, HR; Middaugh, S; Silver, RM; Valter, I; Allenback, G; Arnold, J; Steedman, S; Risinger, A; King, A; Bielory, L; Attanasio, V; Tarantola, J; Centeno, L; Jacob, RG; Medsger, T; Jennings, R; Scheier, M; Vaughan, C; Wasko, MC; Steen, VD; Dunbar-Jacob, J; Tamres, L; Freedman, RR; Mayes, MD; Brejnak, C; Tindall, C; Bielory, L; Thompson, B; Frederick, M; Canner, M; Canner, J; Canner, P; Shaffer, TR; Hill, DR; Kaufmann, PG; Czajkowski, S; Geller, N; Hunsberger, S; Jennings, C; Stevens, WM; Hess, EV; Corson, JA; Jobe, JB; Smith, H; Tilley, B
      Comparison of sustained-release nifedipine and temperature biofeedback fortreatment of primary Raynaud phenomenon - Results from a randomized clinical trial with 1-year follow-up

      ARCHIVES OF INTERNAL MEDICINE
    9. Seibold, JR; Korn, JH; Simms, R; Clements, PJ; Moreland, LW; Mayes, MD; Furst, DE; Rothfield, N; Steen, V; Weisman, M; Collier, D; Wigley, FM; Merkel, PA; Csuka, ME; Hsu, V; Rocco, S; Erikson, M; Hannigan, J; Harkonen, WS; Sanders, ME
      Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial

      ANNALS OF INTERNAL MEDICINE
    10. Freedman, RR; Girgis, R; Mayes, MD
      Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma

      JOURNAL OF RHEUMATOLOGY
    11. Freedman, RR; Girgis, R; Mayes, MD
      Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma

      LANCET
    12. Mayes, MD
      Epidemiologic studies of environmental agents and systemic autoimmune diseases

      ENVIRONMENTAL HEALTH PERSPECTIVES
    13. Kirk, TZ; Mayes, MD
      IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced celldeath

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    14. Lacey, JV; Garabrant, DH; Laing, TJ; Gillespie, BW; Mayes, MD; Cooper, BC; Schottenfeld, D
      Petroleum distillate solvents as risk factors for Undifferentiated Connective Tissue Disease (UCTD)

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    15. DOSS BJ; JACQUES SM; ATTY S; MAYES MD; QURESHI F
      MATERNAL SCLERODERMA - PLACENTAL FINDINGS AND PERINATAL OUTCOME

      Modern pathology
    16. SEIBOLD JR; CLEMENTS PJ; FURST DE; MAYES MD; MCCLOSKEY DA; MORELAND LW; WHITE B; WIGLEY FM; ROCCO S; ERIKSON M; HANNIGAN JF; SANDERS ME; AMENTO EP
      SAFETY AND PHARMACOKINETICS OF RECOMBINANT HUMAN RELAXIN IN SYSTEMIC-SCLEROSIS

      Journal of rheumatology
    17. Doss, BJ; Jacques, SM; Mayes, MD; Qureshi, F
      Maternal scleroderma: Placental findings and perinatal outcome

      HUMAN PATHOLOGY
    18. INJIC Z; MAYES MD
      THE USE OF INDWELLING VENOUS CATHETERS IN PATIENTS WITH SYSTEMIC-SCLEROSIS (SSC)

      Arthritis and rheumatism
    19. LACEY JV; MAYES MD; LAING TJ; GILLESPIE BW; GARABRANT DH; SCHOTTERFEID D
      SELF-REPORTED MEDICAL HISTORY AND MEDICATION USE AMONG WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE

      Arthritis and rheumatism
    20. LACEY JV; GARABRANT DH; MAYES MD; LAING TJ; GILLESPIE BW; SCHOTTENFELD D
      SELF-REPORTED EXPOSURE TO PESTICIDES AND HERBICIDES AS RISK-FACTORS FOR UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD)

      Arthritis and rheumatism
    21. WIGLEY FM; KORN JH; CSUKA ME; MEDSGER TA; ROTHFIELD NF; ELLMAN M; MARTIN R; COLLIER DH; WEINSTEIN A; FURST DE; JIMENEZ SA; MAYES MD; MERKEL PA; GRUBER B; KAUFMAN L; VARGA J; BELL P; KERN J; MARROTT P; WHITE B; SIMMS RW; PHILLIPS AC; SEIBOLD JR
      ORAL ILOPROST TREATMENT IN PATIENTS WITH RAYNAUDS-PHENOMENON SECONDARY TO SYSTEMIC-SCLEROSIS - A MULTICENTER, PLACEBO-CONTROLLED DOUBLE-BLIND STUDY

      Arthritis and rheumatism
    22. MAYES MD
      CLASSIFICATION AND EPIDEMIOLOGY OF SCLERODERMA

      Seminars in cutaneous medicine and surgery
    23. BEEBE JL; LACEY JV; MAYES MD; GILLESPIE BW; COOPER BC; LAING TJ; SCHOTTENFELD D
      REPRODUCTIVE HISTORY, ORAL-CONTRACEPTIVE USE, ESTROGEN REPLACEMENT THERAPY AND THE RISK OF DEVELOPING SCLERODERMA

      Arthritis and rheumatism
    24. LACEY JV; BEEBE JL; MAYES MD; GILLESPIE BW; LAING TJ; COOPER BC
      REPRODUCTIVE HISTORY, ORAL-CONTRACEPTIVE USE, AND ESTROGEN REPLACEMENT THERAPY IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD)

      Arthritis and rheumatism
    25. SEIBOLD JR; KORN J; SIMMS R; CLEMENTS PJ; MORELAND L; MAYES MD; FURST DE; ROTHFIELD N; STEEN V; WEISMAN M; DEMARCO P; COLLIER D; WIGLEY F; MERKEL PA; CSUKA ME; ROCCO S; ERIKSON M; HANNIGAN J; HARKONEN WS; SANDERS ME
      CONTROLLED TRIAL OF RECOMBINANT HUMAN RELAXIN (RHRLXN) IN DIFFUSE SCLERODERMA (DS)

      Arthritis and rheumatism
    26. LACEY JV; GARABRANT DH; GILLESPIE BW; COOPER BC; LAING TJ; MAYES MD; SCHOTTENFELD D
      SELF-REPORTED EXPOSURE TO SOLVENTS IN WOMEN WITH SYSTEMIC-SCLEROSIS (SSC)

      Arthritis and rheumatism
    27. LACEY JV; GARABRANT DH; GILLESPIE W; COOPER BC; LAING TJ; MAYES MD; SCHOTTENFELD D
      SELF-REPORTED EXPOSURE TO SOLVENTS IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE (UCTD)

      Arthritis and rheumatism
    28. MAYES MD; GIANNINI EH; PACHMAN LM; BUYON JP; FLECKMAN P
      CONNECTIVE-TISSUE DISEASE REGISTRIES

      Arthritis and rheumatism
    29. LAING TJ; GILLESPIE BW; TOTH MB; MAYES MD; GALLAVAN RH; BURNS CJ; JOHANNS JR; COOPER BC; KEROACK BJ; WASKO MCM; LACEY JV; SCHOTTENFELD D
      RACIAL-DIFFERENCES IN SCLERODERMA AMONG WOMEN IN MICHIGAN

      Arthritis and rheumatism
    30. MAYES MD
      SCLERODERMA EPIDEMIOLOGY

      Rheumatic diseases clinics of North America
    31. BURNS CJ; LAING TJ; GILLESPIE BW; HEERINGA SG; ALCSER KH; MAYES MD; WASKO MCM; COOPER BC; GARABRANT DH; SCHOTTENFELD D
      THE EPIDEMIOLOGY OF SCLERODERMA AMONG WOMEN - ASSESSMENT OF RISK FROMEXPOSURE TO SILICONE AND SILICA

      Journal of rheumatology
    32. KEENAN PA; JACOBSON MW; SOLEYMANI RM; MAYES MD; STRESS ME; YALDOO DT
      THE EFFECT ON MEMORY OF CHRONIC PREDNISONE TREATMENT IN PATIENTS WITHSYSTEMIC-DISEASE

      Neurology
    33. MAYES MD; LAING TJ; GILLESPIE W; COOPER BC; LACEY JV; HIRSCHENBERGER WS; ATTY SM; SCHOTTENFELD D
      PREVALENCE, INCIDENCE AND SURVIVAL RATES OF SYSTEMIC-SCLEROSIS THE DETROIT METROPOLITAN-AREA

      Arthritis and rheumatism
    34. LAING TJ; GILLESPIE BW; LACEY JV; GARABRANT DH; COOPER BC; HEERINGA SG; ALCSER KH; CHO SW; MAYES MD; SCHOTTENFELD D
      THE ASSOCIATION BETWEEN SILICONE EXPOSURE AND UNDIFFERENTIATED CONNECTIVE-TISSUE DISEASE AMONG WOMEN IN MICHIGAN AND OHIO

      Arthritis and rheumatism
    35. FREEDMAN RR; MAYES MD
      FAMILIAL AGGREGATION OF PRIMARY RAYNAUDS-DISEASE

      Arthritis and rheumatism
    36. SCHOTTENFELD D; BURNS CJ; GILLESPIE BW; LAING TJ; MAYES MD; HEERINGA SG; ALCSER KH
      THE DESIGN OF A POPULATION-BASED CASE-CONTROL STUDY OF SYSTEMIC-SCLEROSIS (SCLERODERMA) - COMMENTARY ON THE UNIVERSITY-OF-MICHIGAN STUDY

      Journal of clinical epidemiology
    37. KIRK TZ; MARK ME; CHUA CC; CHUA BH; MAYES MD
      MYOFIBROBLASTS FROM SCLERODERMA SKIN SYNTHESIZE ELEVATED LEVELS OF COLLAGEN AND TISSUE INHIBITOR OF METALLOPROTEINASE (TIMP-1) WITH 2 FORMSOF TIMP-1

      The Journal of biological chemistry
    38. FREEDMAN RR; BAER RP; MAYES MD
      BLOCKADE OF VASOSPASTIC ATTACKS BY ALPHA(2)-ADRENERGIC BUT NOT ALPHA(1)-ADRENERGIC ANTAGONISTS IN IDIOPATHIC RAYNAUDS-DISEASE

      Circulation
    39. MAYES MD; WOOLEY P; MOSLEY A; DHAR P; INJIC Z; SEGAL B; BRICKMAN C; SEVERSON R
      INTRAVENOUS PULSE CYCLOPHOSPHAMIDE TREATMENT FOR SLE AND THE RISK OF MALIGNANCY

      Arthritis and rheumatism
    40. MORELAND LW; PRATT PW; MAYES MD; POSTLETHWAITE A; WEISMAN MH; SCHNITZER T; LIGHTFOOT R; CALABRESE L; ZELINGER DJ; WOODY JN; KOOPMAN WJ
      DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL USING CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY, CM-T412, IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING CONCOMITANT METHOTREXATE

      Arthritis and rheumatism
    41. CLEGG DO; READING JC; MAYES MD; SEIBOLD JR; HARRIS C; WIGLEY FM; WARD JR; PISKO EJ; WEISMAN MH; LEE P; MORELAND LW; NEUNER R; GALL E; CLEMENTS P; SPINDLER J; LALLY EV
      COMPARISON OF AMINOBENZOATE POTASSIUM AND PLACEBO IN THE TREATMENT OFSCLERODERMA

      Journal of rheumatology
    42. MARK ME; KIRK TZ; ADAMICK C; MOSHIER J; MAYES MD
      IL-6 PARADOXICALLY DECREASES TIMP-1 PRODUCTION IN SCLERODERMA FIBROBLASTS

      Arthritis and rheumatism
    43. MAYES MD; MARK ME; MAYTON ML; LAWRENCE WD; WOOLEY PH
      INCREASED ELASTIN FIBERS IN THE TIGHT-SKIN MOUSE

      Arthritis and rheumatism
    44. DHAR JP; MAYES MD; MOSLEY AD; WOOLEY PH; FERNANDEZMADRID F
      PROLACTIN LEVELS IN LUPUS AND SCLERODERMA

      Arthritis and rheumatism
    45. MAYES MD; KIRK TZ; MARK ME; WOOLEY PH; LAWRENCE WD
      INCREASED ELASTIC FIBERS IN THE DERMIS OF THE TIGHT SKIN MOUSE

      Arthritis and rheumatism
    46. MAYES MD; KIRK TZ; MARK ME; CHUA CC
      MYOFIBROBLASTS IN SCLERODERMA CULTURES SYNTHESIZE ELEVATED LEVELS OF COLLAGEN AND 2 FORMS OF TIMP-1

      Arthritis and rheumatism


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 10:02:16